{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:02:31Z","timestamp":1793361751240,"version":"4.5.0"},"reference-count":57,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Br J Nutr"],"published-print":{"date-parts":[[2018,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study was carried out to evaluate the effects of Se supplementation on metabolic profiles in patients with congestive heart failure (CHF). This randomised double-blind, placebo-controlled trial was performed among fifty-three subjects with CHF, aged 45\u201385 years old. Subjects were randomly allocated into two groups to take either 200 \u00b5g\/d of Se as Se yeast (<jats:italic>n<\/jats:italic> 26) or placebo (<jats:italic>n<\/jats:italic> 27) for 12 weeks. Metabolic profiles were assessed at baseline and at the end of trial. Compared with the placebo, Se supplementation led to significant reductions in serum insulin (\u221218\u00b741 (<jats:sc>sd<\/jats:sc> 27\u00b753) <jats:italic>v<\/jats:italic>. +13\u00b773 (<jats:sc>sd<\/jats:sc> 23\u00b763) pmol\/l, <jats:italic>P<\/jats:italic>&lt;0\u00b7001), homoeostatic model of assessment for insulin resistance (\u22121\u00b701 (<jats:sc>sd<\/jats:sc> 1\u00b761) <jats:italic>v<\/jats:italic>. +0\u00b755 (<jats:sc>sd<\/jats:sc> 1\u00b720), <jats:italic>P<\/jats:italic>&lt;0\u00b7001) and a significant increase in quantitative insulin sensitivity check index (QUICKI) (+0\u00b7007 (<jats:sc>sd<\/jats:sc> 0\u00b703) <jats:italic>v<\/jats:italic>. \u22120\u00b701 (<jats:sc>sd<\/jats:sc> 0\u00b701), <jats:italic>P<\/jats:italic>=0\u00b7007). In addition, Se supplementation significantly decreased LDL-cholesterol (\u22120\u00b723 (<jats:sc>sd<\/jats:sc> 0\u00b729) <jats:italic>v<\/jats:italic>. \u22120\u00b704 (<jats:sc>sd<\/jats:sc> 0\u00b728) mmol\/l, <jats:italic>P<\/jats:italic>=0\u00b703) and total-:HDL-cholesterol ratio (\u22120\u00b747 (<jats:sc>sd<\/jats:sc> 0\u00b731) <jats:italic>v<\/jats:italic>. \u22120\u00b706 (<jats:sc>sd<\/jats:sc> 0\u00b742), <jats:italic>P<\/jats:italic>&lt;0\u00b7001), and significantly increased HDL-cholesterol levels (+0\u00b718 (<jats:sc>sd<\/jats:sc> 0\u00b719) <jats:italic>v<\/jats:italic>. +0\u00b702 (<jats:sc>sd<\/jats:sc> 0\u00b713) mmol\/l, <jats:italic>P<\/jats:italic>=0\u00b7001) compared with the placebo. In addition, taking Se supplements was associated with a significant reduction in high-sensitivity C-reactive protein (hs-CRP) (\u22121880\u00b78 (<jats:sc>sd<\/jats:sc> 3437\u00b75) <jats:italic>v<\/jats:italic>. +415\u00b73 (<jats:sc>sd<\/jats:sc> 2116\u00b75) ng\/ml, <jats:italic>P<\/jats:italic>=0\u00b701), and a significant elevation in plasma total antioxidant capacity (TAC) (+30\u00b79 (<jats:sc>sd<\/jats:sc> 118\u00b70) <jats:italic>v<\/jats:italic>. \u2212187\u00b79 (<jats:sc>sd<\/jats:sc> 412\u00b77) mmol\/l, <jats:italic>P<\/jats:italic>=0\u00b7004) and total glutathione levels (+33\u00b77 (<jats:sc>sd<\/jats:sc> 130\u00b74) <jats:italic>v<\/jats:italic>. \u221239\u00b72 (<jats:sc>sd<\/jats:sc> 132\u00b78) \u00b5mol\/l, <jats:italic>P<\/jats:italic>=0\u00b7003) compared with the placebo. When we applied Bonferroni correction for multiple outcome testing, QUICKI (<jats:italic>P<\/jats:italic>=0\u00b711), LDL-cholesterol (<jats:italic>P<\/jats:italic>=0\u00b751), hs-CRP (<jats:italic>P<\/jats:italic>=0\u00b717), TAC (<jats:italic>P<\/jats:italic>=0\u00b706) and GSH (<jats:italic>P<\/jats:italic>=0\u00b705) became non-significant, and other metabolic profiles did not alter. Overall, our study supported that Se supplementation for 12 weeks to patients with CHF had beneficial effects on insulin metabolism and few markers of cardio-metabolic risk.<\/jats:p>","DOI":"10.1017\/s0007114518001253","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T04:57:56Z","timestamp":1529902676000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":40,"title":["Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1017","volume":"120","author":[{"given":"Fariba","family":"Raygan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Behnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-5397","authenticated-orcid":false,"given":"Vahidreza","family":"Ostadmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Bahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Mansournia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Karamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zatollah","family":"Asemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"key":"S0007114518001253_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(01)00179-9"},{"key":"S0007114518001253_ref18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0043-119544","article-title":"The effects of selenium supplementation on glucose metabolism and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"49","author":"Tabrizi","year":"2017","journal-title":"Horm Metab Res"},{"key":"S0007114518001253_ref48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137680"},{"key":"S0007114518001253_ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.592"},{"key":"S0007114518001253_ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-015-0007-2"},{"key":"S0007114518001253_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2017.04.009"},{"key":"S0007114518001253_ref22","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0840"},{"key":"S0007114518001253_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(03)00103-4"},{"key":"S0007114518001253_ref52","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.639123"},{"key":"S0007114518001253_ref43","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-8-55"},{"key":"S0007114518001253_ref42","doi-asserted-by":"publisher","DOI":"10.1159\/000335470"},{"key":"S0007114518001253_ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-006-9188-2"},{"key":"S0007114518001253_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/57.2.259S"},{"key":"S0007114518001253_ref54","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20317"},{"key":"S0007114518001253_ref24","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1996.0292"},{"key":"S0007114518001253_ref50","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200700346"},{"key":"S0007114518001253_ref55","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.74"},{"key":"S0007114518001253_ref12","first-page":"CD009671","article-title":"Selenium supplementation for the primary prevention of cardiovascular disease","author":"Rees","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"S0007114518001253_ref44","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.6.676"},{"key":"S0007114518001253_ref25","first-page":"581","article-title":"Plasma glutathione in health and in patients with malignant disease","volume":"105","author":"Beutler","year":"1985","journal-title":"J Lab Clin Med"},{"key":"S0007114518001253_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2017.04.022"},{"key":"S0007114518001253_ref57","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/136.1.172"},{"key":"S0007114518001253_ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-9995-7"},{"key":"S0007114518001253_ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-098245"},{"key":"S0007114518001253_ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-017-0351-y"},{"key":"S0007114518001253_ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000039105.49749.6F"},{"key":"S0007114518001253_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.010"},{"key":"S0007114518001253_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.01.032"},{"key":"S0007114518001253_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90063-0"},{"key":"S0007114518001253_ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.07.012"},{"key":"S0007114518001253_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/174182679600300601"},{"key":"S0007114518001253_ref9","first-page":"216","article-title":"Trace element status (Se, Zn, Cu) in heart failure","volume":"6","author":"Kosar","year":"2006","journal-title":"Anadolu Kardiyol Derg"},{"key":"S0007114518001253_ref10","first-page":"53","article-title":"A comparison of selenium concentrations between congestive heart failure patients and healthy volunteers","volume":"7","author":"Ghaemian","year":"2012","journal-title":"J Tehran Heart Cent"},{"key":"S0007114518001253_ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.864"},{"key":"S0007114518001253_ref33","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.0900704"},{"key":"S0007114518001253_ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-015-0600-4"},{"key":"S0007114518001253_ref16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0035-1569276","article-title":"Selenium supplementation affects insulin resistance and serum hs-CRP in patients with type 2 diabetes and coronary heart disease","volume":"48","author":"Farrokhian","year":"2016","journal-title":"Horm Metab Res"},{"key":"S0007114518001253_ref36","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-4-32"},{"key":"S0007114518001253_ref38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S0007114508939830","article-title":"Food-chain selenium and human health: emphasis on intake","volume":"100","author":"Rayman","year":"2008","journal-title":"Br J Nutr"},{"key":"S0007114518001253_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2008.08.005"},{"key":"S0007114518001253_ref21","volume-title":"Food Composition Table of Iran","author":"Azar","year":"1980"},{"key":"S0007114518001253_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2010.12.011"},{"key":"S0007114518001253_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(90)90131-2"},{"key":"S0007114518001253_ref29","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000564"},{"key":"S0007114518001253_ref31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-4-200708210-00175"},{"key":"S0007114518001253_ref34","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114515003499"},{"key":"S0007114518001253_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2012.08.008"},{"key":"S0007114518001253_ref37","doi-asserted-by":"publisher","DOI":"10.1177\/156482650802900201"},{"key":"S0007114518001253_ref39","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12429"},{"key":"S0007114518001253_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2007.11.049"},{"key":"S0007114518001253_ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-010-0362-1"},{"key":"S0007114518001253_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2003.12.008"},{"key":"S0007114518001253_ref49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M703075200"},{"key":"S0007114518001253_ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2015.02.005"},{"key":"S0007114518001253_ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.03.008"},{"key":"S0007114518001253_ref56","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.055301"},{"key":"S0007114518001253_ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt083"}],"updated-by":[{"DOI":"10.1017\/s0007114521002063","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"record-id":"43667"}],"container-title":["British Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007114518001253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T18:56:45Z","timestamp":1555181805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007114518001253\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7,14]]}},"alternative-id":["S0007114518001253"],"URL":"https:\/\/doi.org\/10.1017\/s0007114518001253","relation":{},"ISSN":["0007-1145","1475-2662"],"issn-type":[{"value":"0007-1145","type":"print"},{"value":"1475-2662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,25]]},"assertion":[{"value":"\u00a9 The Authors 2018\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}